Niacin: Too much over the long term may lead to liver damage
Ethics declarations Competing interests SJW is the founder of Ridgeline Therapeutics, HN is a paid employee of Ridgeline Therapeutics and, since manuscript submission, ADW has also become a paid employee of Ridgeline Therapeutics
They have both shown the potential to be blockbuster weight loss drugs, even though neither is approved by the U.S
GLP-1 Injectable Programs GLP-1 injectable medications are a powerful tool for medically guided weight loss
Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: the prospective randomized study of mesenchymal stem cell therapy in patients undergoing cardiac surgery (PROMETHEUS) trial
Research consistently shows that weight regain commonly occurs after discontinuation of GLP-1 therapy